Influence of Coffeeberry Ingestion on Soccer Skill Performance

March 23, 2022 updated by: PepsiCo Global R&D

Influence of Coffeeberry Extract on Soccer Specific Skill Performance After Rest, During Simulated Soccer Match Play, and Following Fatiguing Exercise in Academy Football Players

The study of soccer skill performance has 3 objectives. Objective 1 is to compare effects of coffeeberry (300mg) and placebo ingestion on dribbling speed and precision and passing and shooting speed and accuracy compared to placebo. 30 subjects will be assessed before dosing, after a 1 hr resting absorption period, and after simulated soccer match play. Of these 30, 20 subjects will proceed to Objective 2 (45 minutes of intense simulated soccer match play) and Objective 3 (repeated sprint activity continued until volitional fatigue).

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Scotland
      • Stirling, Scotland, United Kingdom, FK9 4LA
        • University of Stirling, Health Science and Sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 28 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Provide valid informed consent prior to any study procedure
  • Male soccer players age 16 to 28 years
  • 5-year soccer playing experience
  • 1-year regularly soccer training
  • Free of injuries
  • Willing to avoid alcohol in the 48-h period prior to main trials.
  • Willing to avoid caffeine, caffeinated and decaffeinated products, apples, and, berries/cherries for 24-h prior to main trials
  • Willing to record food intake over the 48-h period prior to the first trial and replicate for second trial
  • Willing to abstain from strenuous physical activity for 24-h before all visits

Exclusion Criteria:

  • Smoking
  • Cardiovascular diseases
  • Diabetes or other metabolic disease
  • Presence of injuries
  • Major illnesses or surgery in prior 90 days
  • Participation in another clinical trial in the past month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Coffeeberry beverage
300 mg Coffeeberry extract in 300 ml beverage
One exposure of 300 mg coffeeberry extract in a 300 ml flavored still beverage prior to exercise session
PLACEBO_COMPARATOR: Color and flavor matched beverage
0 mg Coffeeberry extract in 300 ml flavor and color-matched beverage
One 300 ml still beverage, color and flavor matched to experimental beverage prior to exercise session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dribbling speed
Time Frame: During 3.5 hours post consumption
m/sec, increase would be better. Simulated match in an indoor gym with pre-set targets.
During 3.5 hours post consumption
Dribbling precision
Time Frame: During 3.5 hours post consumption
Meters, more accuracy would be better. Simulated match in an indoor gym against pre-set targets.
During 3.5 hours post consumption
Passing accuracy
Time Frame: During 3.5 hours post consumption
1-10 scale, higher score would be better. Simulated match in an indoor gym against pre-set targets.
During 3.5 hours post consumption
Passing speed by Time
Time Frame: During 3.5 hours post consumption
km/h, increased would be better. Simulated match in an indoor gym against pre-set targets.
During 3.5 hours post consumption
Shooting accuracy
Time Frame: During 3.5 hours post consumption
More shots on target would be better. Simulated match in an indoor gym against pre-set targets.
During 3.5 hours post consumption
Shooting speed
Time Frame: During 3.5 hours post consumption
Milliseconds, faster would be better. Simulated match in an indoor gym against pre-set targets.
During 3.5 hours post consumption

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sprint speed
Time Frame: During 3.5 hours post consumption
m/sec, increase would be better. In indoor gym with marked course.
During 3.5 hours post consumption
High-intensity endurance running capacity
Time Frame: During 3.5 hours post consumption
Run time to volitional fatigue in min, increase would be better. In indoor gym with marked course.
During 3.5 hours post consumption

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood analyte concentration: Capillary glucose
Time Frame: During 3.5 hours post consumption
(mmol/L), more regulated would be better
During 3.5 hours post consumption
Blood analyte concentration: Capillary lactate
Time Frame: During 3.5 hours post consumption
(mmol/L), lower (delayed rise) would be better
During 3.5 hours post consumption
Blood analyte concentration: Serum chlorogenic acid
Time Frame: During 3.5 hours post consumption
(mmol/L), n.a. for placebo, introduced to evaluate primary outcomes
During 3.5 hours post consumption
Blood analyte concentration: Serum caffeine
Time Frame: During 3.5 hours post consumption
(ug/mL), n.a. for placebo, Introduced to evaluate primary outcomes
During 3.5 hours post consumption
Rate of Perceived Exertion (RPE)
Time Frame: During 3.5 hours post consumption
By Borg scale, rated 6-20, lower values would be better
During 3.5 hours post consumption
Activation/Deactivation (feelings and mood)
Time Frame: During 3.5 hours post consumption
Checklist of feelings using a 4 point scale from definitely do to definitely don't feel, more relaxed and better mood would be better
During 3.5 hours post consumption
Mental energy
Time Frame: During 3.5 hours post consumption
By Visual Analog Scale (VAS) vertical marking on 100 mm horizontal line, higher energy would be better
During 3.5 hours post consumption
Physical energy
Time Frame: During 3.5 hours post consumption
By Visual Analog Scale (VAS) vertical marking on 100 mm horizontal line, higher energy would be better
During 3.5 hours post consumption
Heart rate
Time Frame: During 3.5 hours post consumption
By electronic reading, lower would be better
During 3.5 hours post consumption
Gut comfort
Time Frame: During 3.5 hours post consumption
By Visual Analog Scale (VAS) vertical marking on 100 mm horizontal scale, no or less nausa, fullness or bloating would be better
During 3.5 hours post consumption
Hydration status
Time Frame: During 3.5 hours post consumption
Urine osmolality in mOsm/kg, comparing pre- vs. post-exercise concentration
During 3.5 hours post consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stuart Galloway, PhD, U. Stirling

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 6, 2019

Primary Completion (ACTUAL)

August 3, 2021

Study Completion (ACTUAL)

August 3, 2021

Study Registration Dates

First Submitted

November 26, 2019

First Submitted That Met QC Criteria

November 26, 2019

First Posted (ACTUAL)

November 29, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 24, 2022

Last Update Submitted That Met QC Criteria

March 23, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skill Performance

Clinical Trials on Coffeeberry beverage

Subscribe